46 - Frank Watanabe, President & CEO at Arcutis Biotherapeutics 💊 🌱 скачать в хорошем качестве

46 - Frank Watanabe, President & CEO at Arcutis Biotherapeutics 💊 🌱

Join us on the latest episode! Our Guest: Frank Watanabe, President & CEO at Arcutis Biotherapeutics. What you'll get out of this episode: -Company Focus: Arcutis Biotherapeutics, under Frank Watanabe, is dedicated to treating inflammatory skin conditions, with three FDA-approved products and a fourth pending. -Significant Milestones: This year, Arcutis launched two new products and partnered with a primary care company to expand its reach. -Patient-Centric Approach: Arcutis prioritizes patient needs by involving dermatology practitioners and patient insights directly in decision-making. -Technological Perspective: While acknowledging AI's potential in drug discovery, Arcutis is focused on tangible, current advancements without prematurely implementing AI. -Expanding Accessibility: Arcutis is actively working to extend its treatments to Medicare and Medicaid markets to support a broader patient demographic. To Learn More About Our Guest And Their Company: LinkedIn   / frank-watanabe-419711   Company LinkedIn   / arcutis-inc   Website https://www.arcutis.com/ Our sponsor for this episode are: Sage Growth Partners https://sage-growth.com/ BioBreakthroughs is part of the Slice of Healthcare podcast network: LinkedIn:   / sliceofhealthcare